Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lee Goodglick

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Cellular and Molecular Gastroenterology and Hepatology|February 9, 2017
Microgeographic Proteomic Networks of the Human Colonic Mucosa and Their Association With Inflammatory Bowel DiseaseXiaoxiao Li, James LeBlanc, David Elashoff, et al.
BMC Cancer|June 22, 2011
Expression of phosphorylated raf kinase inhibitor protein (pRKIP) is a predictor of lung cancer survivalSara Huerta-Yepez, Nam K Yoon, Angeles Hernandez-Cueto, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 5, 2003
COX-2-dependent stabilization of survivin in non-small cell lung cancerKostyantyn Krysan, Farrukh H Merchant, Li Zhu, et al.
Oncotarget|February 20, 2016
Bladder cancer cells secrete while normal bladder cells express but do not secrete AGR2Melissa E Ho, Sue-Ing Quek, Lawrence D True, et al.
Biochemical and Biophysical Research Communications|June 14, 2005
IL-20, an anti-angiogenic cytokine that inhibits COX-2 expressionNathalie Heuzé-Vourc'h, Ming Liu, Harnisha Dalwadi, et al.
Inflammatory Bowel Diseases|June 24, 2011
Host-microbe relationships in inflammatory bowel disease detected by bacterial and metaproteomic analysis of the mucosal-luminal interfaceLaura L Presley, Jingxiao Ye, Xiaoxiao Li, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|February 21, 2012
Na,K-ATPase is a target of cigarette smoke and reduced expression predicts poor patient outcome of smokers with lung cancerThu P Huynh, Vei Mah, Valerie B Sampson, et al.
Molecular Cancer Therapeutics|January 23, 2014
Rationale and preclinical efficacy of a novel anti-EMP2 antibody for the treatment of invasive breast cancerMaoyong Fu, Erin L Maresh, Gustavo F Helguera, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 8, 2011
Lung cancer chemoprevention with celecoxib in former smokersJenny T Mao, Michael D Roth, Michael C Fishbein, et al.
The Journal of Biological Chemistry|March 20, 2014
Epithelial membrane protein-2 (EMP2) activates Src protein and is a novel therapeutic target for glioblastomaYu Qin, Maoyong Fu, Masamichi Takahashi, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Cellular and Molecular Gastroenterology and Hepatology|February 9, 2017
Microgeographic Proteomic Networks of the Human Colonic Mucosa and Their Association With Inflammatory Bowel DiseaseXiaoxiao Li, James LeBlanc, David Elashoff, et al.
BMC Cancer|June 22, 2011
Expression of phosphorylated raf kinase inhibitor protein (pRKIP) is a predictor of lung cancer survivalSara Huerta-Yepez, Nam K Yoon, Angeles Hernandez-Cueto, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 5, 2003
COX-2-dependent stabilization of survivin in non-small cell lung cancerKostyantyn Krysan, Farrukh H Merchant, Li Zhu, et al.
Oncotarget|February 20, 2016
Bladder cancer cells secrete while normal bladder cells express but do not secrete AGR2Melissa E Ho, Sue-Ing Quek, Lawrence D True, et al.
Biochemical and Biophysical Research Communications|June 14, 2005
IL-20, an anti-angiogenic cytokine that inhibits COX-2 expressionNathalie Heuzé-Vourc'h, Ming Liu, Harnisha Dalwadi, et al.
Inflammatory Bowel Diseases|June 24, 2011
Host-microbe relationships in inflammatory bowel disease detected by bacterial and metaproteomic analysis of the mucosal-luminal interfaceLaura L Presley, Jingxiao Ye, Xiaoxiao Li, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|February 21, 2012
Na,K-ATPase is a target of cigarette smoke and reduced expression predicts poor patient outcome of smokers with lung cancerThu P Huynh, Vei Mah, Valerie B Sampson, et al.
Molecular Cancer Therapeutics|January 23, 2014
Rationale and preclinical efficacy of a novel anti-EMP2 antibody for the treatment of invasive breast cancerMaoyong Fu, Erin L Maresh, Gustavo F Helguera, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 8, 2011
Lung cancer chemoprevention with celecoxib in former smokersJenny T Mao, Michael D Roth, Michael C Fishbein, et al.
The Journal of Biological Chemistry|March 20, 2014
Epithelial membrane protein-2 (EMP2) activates Src protein and is a novel therapeutic target for glioblastomaYu Qin, Maoyong Fu, Masamichi Takahashi, et al.
Pageof 7